July 20, 2022 | Renato Lopes and C. Michael Gibson discuss PRONOUNCE comparing the cardiovascular safety of degarelix vs. leuprolide in patients with advanced prostate cancer and CVD. Talking Points · ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results